https://www.selleckchem.com/products/qnz-evp4593.html Patients with chronic kidney disease develop acute kidney injury (AKI) following percutaneous coronary intervention (PCI). We report a case highlighting the benefits of zero-contrast left main bifurcation PCI in an 82-year-old male with non-ST elevation myocardial infarction and contrast-induced AKI following coronary angiography. The patient was on routine follow-up, and he was stable and asymptomatic at nine months follow-up.We report a rare case of a 39-year-old male who presented with acute inferior wall myocardial infarction (IWMI). Coronary angiography revealed an anomalous single coronary artery arising from the right coronary cusp. Premature atherosclerotic coronary artery disease (CAD) with critical stenosis in the mid right coronary artery (RCA), proximal posterior left ventricular (PLV) artery, and distal left circumflex (LCX) artery was detected during angiography. The patient managed successfully by percutaneous coronary interventions (PCI) with drug-eluting stents (DESs) by radial approach.Polyunsaturated fatty acids (PUFAs) contain ≥2 double-bond desaturations within the acyl chain. Omega-3 (n-3) and Omega-6 (n-6) PUFAs are the two known important families in human health and nutrition. In both Omega families, many forms of PUFAs exist α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) from the n-3 family and linoleic acid (LA), dihomo-γ-linolenic acid (DGLA), and arachidonic acid (AA) from the n-6 family are the important PUFAs for human health. Omega-3 and Omega-6 PUFAs are competitively metabolized by the same set of desaturation, elongation, and oxygenase enzymes. The lipid mediators produced from their oxidative metabolism perform opposing (antagonistic) functions in the human body. Except for DGLA, n-6 PUFA-derived lipid mediators enhance inflammation, platelet aggregation, and vasoconstriction, while those of n-3 inhibit inflammation and platelet aggregation